Trilogy Capital Portfolio holdings
Top Buys
| 1 |
iShares MSCI Intl Quality Factor ETF
IQLT
|
+$12.4M |
| 2 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$10.7M |
| 3 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$10M |
| 4 |
Freeport-McMoran
FCX
|
+$8.4M |
| 5 |
Avantis International Small Cap Value ETF
AVDV
|
+$7.29M |
Top Sells
| 1 |
iShares Emerging Markets Equity Factor ETF
EMGF
|
+$16.2M |
| 2 |
Hartford Multifactor Developed Markets ex-US ETF
RODM
|
+$11.2M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$8.53M |
| 4 |
Avantis International Equity ETF
AVDE
|
+$6.56M |
| 5 |
iShares Select Dividend ETF
DVY
|
+$6.18M |
Sector Composition
| 1 | Technology | 2.85% |
| 2 | Financials | 1.14% |
| 3 | Healthcare | 1.12% |
| 4 | Energy | 0.85% |
| 5 | Industrials | 0.83% |
Similar funds
Trilogy Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Trilogy Capital held 350 positions worth $1.84B, up 6% from $1.74B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trilogy Capital deployed $102M of net new capital in Q2 2024, opening 61 new positions and adding to 154 existing holdings. Its largest new stake was iShares MSCI Intl Quality Factor ETF: 316,098 shares worth $12.3M.
By sector, the portfolio is most concentrated in Technology at 2.8% of assets, up from 1.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Hartford Multifactor Developed Markets ex-US ETF, an estimated $11.2M trimmed.
- Trilogy Capital's largest Q2 2024 buy was iShares MSCI Intl Quality Factor ETF: 316,098 shares worth $12.3M.
- Trilogy Capital added most to Avantis Emerging Markets Equity ETF in Q2 2024, an estimated $10.7M increase.
- Trilogy Capital's biggest Q2 2024 reduction was Hartford Multifactor Developed Markets ex-US ETF, cutting an estimated $11.2M.
- Trilogy Capital fully exited iShares Emerging Markets Equity Factor ETF in Q2 2024, selling an estimated $16.2M.
- Trilogy Capital's ten largest holdings make up 31% of its $1.84B portfolio in Q2 2024.
- Trilogy Capital opened 61 new positions and closed 35 in Q2 2024.
- Trilogy Capital's portfolio value rose 6% quarter-over-quarter to $1.84B.
Based on Trilogy Capital's 13F filing for Q2 2024, filed 23 Jul 2024.